Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 118 entries
View as:

A Study to Evaluate ACT-132577 in Healthy Subjects and in People With Severe Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT03165071 Org: User:
Start: 06/03/17 End: 10/27/17 Due: 10/27/18

Tezosentan in Patients With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01094067 Org: User:
Start: 09/01/10 End: 09/01/11 Due: 09/01/12

A Study to Investigate the Effect of Itraconazole on the Way the Body Absorbs, Distributes, and Gets Rid of ACT-1004-1239 Given as a Single Dose of 10 mg to Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05549531 Org: User:
Start: 10/01/22 End: 10/20/22 Due: 10/20/23

A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03907215 Org: User:
Start: 04/09/19 End: 06/26/19 Due: 06/26/20

A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04250506 Org: User:
Start: 02/28/20 End: 07/22/20 Due: 07/22/21

A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan

Phase: N/A Priority: Normal
NCT ID: NCT03596294 Org: User:
Start: 07/19/18 End: 08/03/18 Due: 08/03/19

Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441

Phase: N/A Priority: Normal
NCT ID: NCT02479204 Org: User:
Start: 04/28/15 End: 05/01/16 Due: 05/01/17

A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03586570 Org: User:
Start: 07/17/18 End: 09/10/18 Due: 09/10/19

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-451840 in Healthy Subjects (Part A)

Phase: N/A Priority: Normal
NCT ID: NCT02186002 Org: User:
Start: 12/31/11 End: 04/30/12 Due: 04/30/13

A Study to Assess the Safety and Pharmacokinetics of Lucerastat (OGT 923) in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02944487 Org: User:
Start: 10/31/02 End: 12/31/02 Due: 12/31/03

A Study of ACT-541468 in Healthy Japanese and Caucasian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03101189 Org: User:
Start: 03/15/17 End: 04/26/17 Due: 04/26/18

A Study to Evaluate if AC-084 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02905253 Org: User:
Start: 09/12/16 End: 12/10/17 Due: 12/10/18

Tezosentan in the Treatment of Acute Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00524433 Org: User:
Start: 04/30/03 End: 01/31/05 Due: 01/31/06

Single-ascending Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-281959 / ACT-246475 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01954615 Org: User:
Start: 10/31/11 End: 03/31/12 Due: 03/31/13

A Study in Healthy Subjects to Investigate Whether Administration of Lucerastat Can Affect Normal Heart Function

Phase: N/A Priority: Normal
NCT ID: NCT03832452 Org: User:
Start: 02/14/19 End: 04/22/19 Due: 04/22/20

A Phase 1 Trial to Investigate the Biological Equivalence of 5 × 10 mg Tablets and 2 × 25 mg Tablets of Daridorexant in Healthy Male and Female Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT05877222 Org: User:
Start: 06/23/23 End: 08/04/23 Due: 08/04/24

Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206

Phase: N/A Priority: Normal
NCT ID: NCT01954589 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478

Phase: N/A Priority: Normal
NCT ID: NCT04452006 Org: User:
Start: 07/20/20 End: 04/20/21 Due: 04/20/22

Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01264692 Org: User:
Start: 02/28/11 End: 02/29/12 Due: 02/28/13

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03545191 Org: User:
Start: 06/04/18 End: 02/25/20 Due: 02/25/21

A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Midazolam and Warfarin in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05480488 Org: User:
Start: 08/23/22 End: 10/06/22 Due: 10/06/23

Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®

Phase: N/A Priority: Normal
NCT ID: NCT06498128 Org: User:
Start: 11/21/24 End: 03/31/33 Due: 03/31/34

A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)

Phase: N/A Priority: Normal
NCT ID: NCT03245229 Org: User:
Start: 08/10/17 End: 09/18/17 Due: 09/18/18

A Study to Evaluate ACT-132577 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03100591 Org: User:
Start: 03/28/17 End: 04/18/17 Due: 04/18/18

A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives

Phase: N/A Priority: Normal
NCT ID: NCT06799884 Org: User:
Start: 01/18/25 End: 02/21/25 Due: 02/21/26